[Present status of dermatology].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy; D008094:Lithium / Q000009:adverse effects; D008297:Male; D008545:Melanoma / Q000453:epidemiology / Q000628:therapy; D010396:Penicillamine / Q000009:adverse effects; D011565:Psoriasis / Q000628:therapy; D012871:Skin Diseases / Q000628:therapy*; D012878:Skin Neoplasms / Q000453:epidemiology / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008094:Lithium; D010396:Penicillamine
Actualités dermatologiques.